From each FDA label

GLP-1 dosage chart: every brand's schedule

Every GLP-1 starts low and goes up in steps to reduce stomach side effects. Below, how each brand starts and where it tops out, quoted from its own FDA label. Labels are read from DailyMed every day; the newest revision here is Aug 28, 2026.

From each FDA label

Dosage chart by brand

The soonest each label's schedule allows. A clinician can go slower, and the Wegovy and Saxenda labels say to consider delaying a step that is not tolerated.

Foundayo

Foundayo dosage schedule
When	Dose
Days 1 to 30	0.8 mg
Days 31 to 60	2.5 mg
Day 61 on	5.5 mg
Day 91 or later	9 mgif needed and tolerated
Day 121 or later	14.5 mgif needed and tolerated
Day 151 or later	17.2 mgif needed and tolerated

Mounjaro

Mounjaro dosage schedule
When	Dose
Weeks 1 to 4	2.5 mg
Week 5 or later	5 mgif more control is needed
Week 9 or later	7.5 mgif more control is needed
Week 13 or later	10 mgif more control is needed
Week 17 or later	12.5 mgif more control is needed
Week 21 or later	15 mgif more control is needed

Ozempic

Ozempic Injection dosage schedule
Injection	Dose
Weeks 1 to 4	0.25 mg
Weeks 5 to 8	0.5 mg
Week 9 or later	1 mgif more control is needed
Week 13 or later	2 mgif more control is needed

Rybelsus and Ozempic tablets

Rybelsus and Ozempic tablets Rybelsus dosage schedule
Rybelsus	Dose
Days 1 to 30	3 mg
Days 31 to 60	7 mg
Day 61 or later	14 mgif more control is needed

Rybelsus and Ozempic tablets Ozempic tablets dosage schedule
Ozempic tablets	Dose
Days 1 to 30	1.5 mg
Days 31 to 60	4 mg
Day 61 or later	9 mgif more control is needed

Saxenda

Saxenda dosage schedule
When	Dose
Week 1	0.6 mg
Week 2	1.2 mg
Week 3	1.8 mg
Week 4	2.4 mg
Week 5 on	3 mg

Trulicity

Trulicity dosage schedule
When	Dose
Weeks 1 to 4	0.75 mg
Week 5 or later	1.5 mgif more control is needed
Week 9 or later	3 mgif more control is needed
Week 13 or later	4.5 mgif more control is needed

Victoza

Victoza dosage schedule
When	Dose
Week 1	0.6 mg
Week 2 on	1.2 mg
Week 3 or later	1.8 mgif more control is needed

Wegovy

Wegovy Injection dosage schedule
Injection	Dose
Weeks 1 to 4	0.25 mg
Weeks 5 to 8	0.5 mg
Weeks 9 to 12	1 mg
Weeks 13 to 16	1.7 mg
Week 17 on	2.4 mg
After at least 4 weeks on 2.4 mg	7.2 mgif tolerated and more weight loss is indicated

Wegovy Tablet dosage schedule
Tablet	Dose
Days 1 to 30	1.5 mg
Days 31 to 60	4 mg
Days 61 to 90	9 mg
Day 91 on	25 mg

Zepbound

Zepbound dosage schedule
When	Dose
Weeks 1 to 4	2.5 mg
Weeks 5 to 8	5 mg
Week 9 or later	7.5 mgif needed and tolerated
Week 13 or later	10 mgif needed and tolerated
Week 17 or later	12.5 mgif needed and tolerated
Week 21 or later	15 mgif needed and tolerated

Compounded vials

Why there is no chart in units

The doses here are milligrams from FDA-approved labels. A compounded vial's units depend on that vial's own strength, so one chart in units cannot fit every vial, and the same number of units can be a different dose from another pharmacy. FDA says it has received reports of adverse events, some requiring hospitalization, that may be related to patients measuring incorrect doses and health care professionals miscalculating them. Ask the prescriber or pharmacy to show you the amount for your vial, and read the vial's own label each time you get a new one.

Word for word

How each brand starts and tops out

Brand	Starting dose	Maintenance or highest dose	Label
Byetta	Initiate BYETTA at 5 mcg administered subcutaneously twice daily at any time within the 60-minute period before the morning and evening meals (or before the two main meals of the day, approximately 6 hours or more apart).	See the full schedule.	Sep 2, 2025
Foundayo	The starting dosage is 0.8 mg orally once daily.	The maximum dosage of FOUNDAYO is 17.2 mg once daily.	Jul 29, 2026
Mounjaro	The recommended starting dosage of MOUNJARO is 2.5 mg injected subcutaneously once weekly.	The maximum dosage of MOUNJARO is: 15 mg injected subcutaneously once weekly in adults. 10 mg injected subcutaneously once weekly in pediatric patients.	Aug 27, 2026
Ozempic	Initiate OZEMPIC with a dosage of 0.25 mg injected subcutaneously once weekly for 4 weeks.	The maximum recommended dosage is 2 mg once weekly.	Jun 1, 2026
Rybelsus and Ozempic tablets	Starting Dosage (Initiation Phase) (Days 1 to 30): The recommended starting dosage is 3 mg orally once daily (this dosage is not effective for glycemic control).	See the full schedule.	Jan 30, 2026
Saxenda	Initiate SAXENDA with a dose of 0.6 mg daily for one week.	For pediatric patients, the recommended maintenance dosage of SAXENDA is 3 mg daily.	Feb 25, 2026
Trulicity	The recommended starting dosage of TRULICITY is 0.75 mg injected subcutaneously once weekly.	The maximum recommended dosage is 4.5 mg injected subcutaneously once weekly.	Jun 16, 2026
Victoza	The recommended starting dosage of VICTOZA is 0.6 mg injected subcutaneously once daily for one week.	If additional glycemic control is required, increase the dosage to the maximum recommended dosage of 1.8 mg injected subcutaneously once daily after at least one week of treatment with the 1.2 mg once daily dosage.	Oct 14, 2025
Wegovy	The recommended starting dosage of WEGOVY injection is 0.25 mg administered subcutaneously once weekly.	For patients who tolerate the 2.4 mg dosage for at least 4 weeks and additional weight reduction is clinically indicated, the dosage may be increased to a maximum dosage of 7.2 mg subcutaneously once weekly.	Jun 18, 2026
Zepbound	The recommended starting dosage of ZEPBOUND for all indications is 2.5 mg injected subcutaneously once weekly for 4 weeks.	The maximum dosage of ZEPBOUND for all indications is 15 mg injected subcutaneously once weekly.	Aug 28, 2026

Dosing is decided by your clinician. This is each label's text for reference, not instructions for you.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.